Health ❯ Healthcare ❯ Obesity
Mounjaro Clinical Trials Mounjaro and Wegovy Novo Nordisk Ozempic Semaglutide and Tirzepatide Tirzepatide Market Trends Semaglutide Usage GLP-1 Medicines
Q2 revenue topped $15 billion, prompting a higher full-year forecast following disappointing weight-loss results for its experimental oral obesity therapy.
